Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1M Sell
77,707
-648
-0.8% -$134K 0.41% 56
2026
Q1
$17.6M Buy
78,355
+1,976
+3% +$492K 0.5% 46
2025
Q4
$18.4M Sell
76,379
-1,077
-1% -$275K 0.54% 45
2025
Q3
$21.2M Buy
77,456
+22,741
+42% +$6.21M 0.63% 41
2025
Q2
$14.1M Buy
54,715
+1,113
+2% +$265K 0.51% 49
2025
Q1
$12M Sell
53,602
-755
-1% -$176K 0.44% 56
2024
Q4
$12.4M Sell
54,357
-4,607
-8% -$1.11M 0.44% 52
2024
Q3
$14.4M Sell
58,964
-22
-0% -$4.92K 0.51% 40
2024
Q2
$11.3M Buy
58,986
+8,747
+17% +$1.77M 0.44% 48
2024
Q1
$9.95M Buy
50,239
+1,611
+3% +$295K 0.38% 58
2023
Q4
$8.36M Buy
48,628
+18,903
+64% +$2.9M 0.33% 72
2023
Q3
$4.4M Buy
+29,725
New +$5.37M 0.19% 114
2019
Q2
Sell
-2,167
Closed -$225K 116
2019
Q1
$225K Hold
2,167
0.02% 110
2018
Q4
$247K Hold
2,167
0.02% 115
2018
Q3
$250K Hold
2,167
0.02% 106
2018
Q2
$224K Hold
2,167
0.02% 106
2018
Q1
$213K Buy
+2,167
New +$205K 0.02% 119

Other funds holding RMD

Addenda Capital's RMD Position: Q2 2026 in Review

Addenda Capital reduced its ResMed (RMD) stake by 0.83% in Q2 2026, selling an estimated $134K and leaving 77,707 shares worth $15.1M. The position accounts for 0.41% of the portfolio, ranked #56.

Addenda Capital first reported a position in RMD in Q1 2018 and has held it in 17 quarters since. The position peaked at $21.2M in Q3 2025. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Addenda Capital held 77,707 shares of ResMed worth $15.1M as of Q2 2026.
  • Addenda Capital sold 648 ResMed shares in Q2 2026, an estimated $134K.
  • ResMed made up 0.41% of Addenda Capital's portfolio in Q2 2026, its #56 holding.
  • Addenda Capital first reported a position in ResMed in Q1 2018 and has held it in 17 quarters since.
  • Addenda Capital's ResMed position peaked at $21.2M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Addenda Capital's 13F filing for Q2 2026, filed 14 Jul 2026.